Research and Development

Showing 15 posts of 9614 posts found.

oxford-biodynamics-logo

Oxford BioDynamics installs new SVP of Commercial Development

March 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oxford BioDynamics

Oxford BioDynamics, a biotech focused on the discovery and development of novel epigenetics biomarkers, has announced the appointment of Martin …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

The past week in the industry has brought much hope for patients with the news of significant research data developments …
thomas_headshot

BMS finds replacement for retiring CSO

March 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb

Bristol-Myers Squibb has announced the appointment of Dr. Thomas J. Lynch, Jr., to the position of Executive Vice President and …
kingscollegechapelwest

Cambridge University announces ‘world-leading’ industry-academia collaboration initiative

March 9, 2017 Medical Communications, Research and Development University of Cambridge

The University of Cambridge has announced a new initiative that seeks to build a bridge between industry and academia in …
charity_gifts_for_children_with_cancer_foundation_vanessa_isabel

Looming Brexit sparks fears for child cancer trials, experts warn

March 9, 2017 Medical Communications, Research and Development EU, ICR, brexit

The trials of cancer treatments in the EU are already at a low level and Brexit has experts worried that …
park-profile-trans

Keapstone Therapeutics created out of Sheffield Uni and Parkinson’s UK link

March 8, 2017 Research and Development Keapstone therapeutics, Parkinson's UK, University of Sheffield

The University of Sheffield and Parkinson’s UK has created, in a first-of-a-kind, a virtual biotech company for developing therapies against …
acute_leukemia-all

New drug combination gives hope for acute myeloid leukaemia treatment

March 8, 2017 Research and Development acute myeloid leukaemia

A new trial in the US hopes to marry a new pair of drugs as a combination treatment for acute …
trevor-philips

Vectura’s COO set to step down

March 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing vectura

Vectura’s Chief Operating Officer, Trevor Phillips, will step down from the board on 25 May before leaving the company on …
amgen_hq

FDA and NICE approve of first new hyperparathyroidism drug in 12 years

March 8, 2017 Research and Development, Sales and Marketing FDA, NICE, Parsabiv, hyperparathyroidism

The FDA has given the go-ahead for Amgen’s hyperparathyroidism (HPT) therapy Parsabiv (etelcalcetide), marking the first new treatment for patients …
web_scientist-filling-out-form---credit-national-institutes-of-health

Diabetes drug could be key to treating aggressive breast cancer, research suggests

March 8, 2017 Research and Development Cancer, diabetes

Researchers from the Zhejiang University School of Medicine have identified that the function of metabolic enzyme AKR1B1 is key to …
child

Research gives hope of potential treatment for most deadly paediatric brain tumour

March 8, 2017 Research and Development

A study conducted by researchers from Northwestern Medicine and Ann & Robert H. Lurie Children’s Hospital of Chicago has given …
gdd_logo_002

BeiGene to develop $330 million biologics plant

March 7, 2017 Manufacturing and Production, Research and Development BeiGene, China, Guangzhou

BeiGene, a Chinese biotech company, and Guangzhou GET Technology Development, an affiliate of Guangzhou Development District, will partner in the …
shutterstock_38078521

Researchers discover worrying new antibiotic-resistance gene variant

March 7, 2017 Manufacturing and Production, Research and Development drug resistance

A new variant of a human gene which is known to cause significant drug resistance in patients has been discovered …

Lilly posts impressive psoriasis results in comparison study

March 6, 2017 Research and Development, Sales and Marketing J&J, JJ, Stelara, Taltz, lilly

Eli Lilly has revealed strong results in a study comparing its psoriasis treatment, Taltz (ixekizumab), to Johnson & Johnson’s Stelara. …
The Gateway to Local Adoption Series

Latest content